Drug
adagrasib
Marketed as KRAZATI.
Generic name
adagrasib
Brand names
KRAZATI
First FDA approval
2022-12-12
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216340 | KRAZATI | 2022-12-12 | BRISTOL |
Manufacturers
BRISTOL
Frequently asked questions
When was adagrasib FDA approved?
Earliest FDA approval on record: 2022-12-12.
What brand names are sold as adagrasib?
KRAZATI.
Sources
Appeal a adagrasib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com